Editas Medicine, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Editas Medicine, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Editas Medicine, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $37M, a 6.15% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $37M +$2.14M +6.15% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $31.4M -$4.9M -13.5% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $33.7M -$9.97M -22.8% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $31.9M +$9.4M +41.7% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $34.8M +$14.1M +68.4% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $36.3M +$12.9M +54.9% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $43.6M +$17.5M +66.8% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $22.5M -$5.27M -19% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $20.7M -$9.65M -31.8% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $23.5M -$5.85M -20% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $26.2M +$1.05M +4.16% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $27.8M +$1.4M +5.32% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $30.3M +$1.75M +6.11% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $29.3M +$2.28M +8.45% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $25.1M -$3.63M -12.6% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $26.4M +$8.72M +49.3% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $28.6M +$11.1M +63.5% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $27M +$8.54M +46.2% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $28.8M +$9.3M +47.8% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $17.7M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $17.5M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $18.5M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $19.5M Jan 1, 2019 10-K 2021-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.